SCHEMBL4038407

SCHEMBL4038407

OCc1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.71
PDGFRB P09619 3/20 0.71
KIT P10721 3/20 0.71
FLT4 P35916 3/20 0.71
MAP3K20 Q9NYL2 2/20 0.71
ILK Q13418 1/20 0.71
FLT1 P17948 12/20 0.40
CSF1R P07333 2/20 0.38
CIT O14578 1/20 0.38
EGFR P00533 1/20 0.38
HLA-A P04439 1/20 0.38
RET P07949 1/20 0.38
PDGFRA P16234 1/20 0.38
RPS6KB1 P23443 1/20 0.38
FRK P42685 1/20 0.38
CDK8 P49336 1/20 0.38
DDR1 Q08345 1/20 0.38
STK3 Q13188 1/20 0.38
PTK6 Q13882 1/20 0.38
MAP3K19 Q56UN5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24390155 0.87 KDR (0.72) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL2199182 0.86 KDR (0.68) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL2200373 0.85 KDR (0.80) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL4037739 0.84 KDR (0.81) KDRPDGFRBKITFLT4MAP3K20
Telatinib SCHEMBL1250560 0.83 KDR (1.00) KDRPDGFRBKITFLT4MAP3K20
Telatinib SCHEMBL29884336 0.83 KDR (1.00) KDRPDGFRBKITFLT4MAP3K20
Telatinib SCHEMBL29353813 0.83 KDR (1.00) KDRPDGFRBKITFLT4MAP3K20
Telatinib SCHEMBL4038729 0.82 KDR (0.98) KDRPDGFRBKITFLT4MAP3K20
Telatinib SCHEMBL4037375 0.82 KDR (0.98) KDRPDGFRBKITFLT4MAP3K20
SCHEMBL4038488 0.82 KDR (0.84) KDRPDGFRBKITFLT4MAP3K20

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1284977-B1 THIENODIBENZOAZULENE COMPOUNDS AS TUMOR NECROSIS FACTOR INHIBITORS GLAXOSMITHKLINE ZAGREB (HR) 2009-06-24 EP claimed
EP-1228063-B1 SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY BAYER CORP (US) 2009-02-11 EP claimed